Epidemiology of neurodegenerative diseases in sub-Saharan Africa: A systematic review

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Lekoubou, Alain ^a   Echouffo Tcheugui, Justin B ^b,c   Kengne, Andre P ^d,e,f,g  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b EMORY UNIVERSITY   (United States)

^c MEDSTAR HEALTH RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Dementia; HIV related cognitive impairment; Neurodegenerative diseases; Parkinsonism; Sub Saharan Africa

Indexed keywords

AFRICA SOUTH OF THE SAHARA; CENTRAL NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; COMPLICATION; DEMENTIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEURODEGENERATIVE DISEASES;

AFRICA SOUTH OF THE SAHARA; CENTRAL NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; DEMENTIA; FEMALE; HIV INFECTIONS; HUMANS; MALE; NEURODEGENERATIVE DISEASES;

EID: 84902902446     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-653     Document Type: Review

References (164)

1. World Population Prospects: The 2012 Revision. http://esa.un.org/unpd/ wpp/unpp/panel-indicators.htm
2. World Population Ageing 2013. http://www.un.org/en/development/desa/ population/publications/pdf/ageing/WorldPopulationAgeingReport2013.pdf
3. Aging and HIV-related cognitive loss. Mateen FJ, Mills EJ, Jama 2012 308 4 349 350
4. Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies. Okubadejo NU, Bower JH, Rocca WA, Maraganore DM, Mov Disord 2006 21 12 2150 2156 (Pubitemid 46140428)
5. Parkinson's disease in sub-Saharan Africa: step-by-step into the challenge. Cilia R, Akpalu A, Cham M, Bonetti A, Amboni M, Faceli E, Pezzoli G, Neurodegener Dis Manag 2011 1 3 194 202
6. The epidemiology of dementia in Africa: a review. Ineichen B, Soc Sci Med 2000 50 11 1673 1677 (Pubitemid 30129139)
7. An estimate of the prevalence of dementia in Africa: A systematic analysis. George-Carey R, Adeloye D, Chan KY, Paul A, Kolcic I, Campbell H, Rudan I, J Glob Health 2012 2 2 20401
8. Juvenile and adult-onset ALS/MND among Africans: incidence, phenotype, survival: a review. Marin B, Kacem I, Diagana M, Boulesteix M, Gouider R, Preux PM, Couratier P, Amyotroph Lateral Scler 2012 13 3 276 283
9. International studies in dementia with particular emphasis on populations of African origin. Hendrie HC, Murrell J, Gao S, Unverzagt FW, Ogunniyi A, Hall KS, Alzheimer Dis Assoc Disord 2000 20 42 S46
10. Frequency of movement disorders in an Ethiopian university practice. Bower JH, Teshome M, Melaku Z, Zenebe G, Mov Disord 2005 20 9 1209 1213 (Pubitemid 41632213)
11. Cognitive dysfunction in Nigerians with Parkinson's disease. Akinyemi RO, Okubadejo NN, Akinyemi JO, Owolabi MO, Owolabi LF, Ogunniyi A, Mov Disord 2008 23 10 1378 1383
12. Parkinson's disease in blacks. Observations on epidemiology in Natal. Cosnett JE, Bill PL, S Afr Med J 1988 73 5 281 283 (Pubitemid 18095089)
13. The prevalence of Parkinson's disease in rural Tanzania. Dotchin C, Msuya O, Kissima J, Massawe J, Mhina A, Moshy A, Aris E, Jusabani A, Whiting D, Masuki G, Walker R, Mov Disord 2008 23 11 1567 1672
14. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Schoenberg BS, Osuntokun BO, Adeuja AO, Bademosi O, Nottidge V, Anderson DW, Haerer AF, Neurology 1988 38 4 645 646
15. Parkinsonism in a population of northern Tanzania: a community-based door-to-door study in combination with a prospective hospital-based evaluation. Winkler AS, Tutuncu E, Trendafilova A, Meindl M, Kaaya J, Schmutzhard E, Kassubek J, J Neurol 2010 257 5 799 805
16. Epidemiological features of degenerative brain diseases as they occurred in Yaounde referral hospitals over a 9-year period. Kengne AP, Dzudie A, Dongmo L, Neuroepidemiology 2006 27 4 208 211 (Pubitemid 46005740)
17. Parkinson's disease in the African. Lombard A, Gelfand M, Cent Afr J Med 1978 24 1 5 8 (Pubitemid 8288741)
18. Parkinsonism in the Nigerian African: a prospective study of 217 patients. Osuntokun BO, Bademosi O, East Afr Med J 1979 56 11 597 607 (Pubitemid 10182845)
19. Neurological disorders in Nigerian Africans: a community-based study. Osuntokun BO, Adeuja AO, Schoenberg BS, Bademosi O, Nottidge VA, Olumide AO, Ige O, Yaria F, Bolis CL, Acta Neurol Scand 1987 75 1 13 21 (Pubitemid 17027275)
20. Mutations in the parkin gene are a minor cause of Parkinson's disease in the South African population. Haylett WL, Keyser RJ, du Plessis MC, van der Merwe C, Blanckenberg J, Lombard D, Carr J, Bardien S, Parkinsonism Relat Disord 2012 18 1 89 92
21. Profile of neurological admissions at the University of Nigeria Teaching Hospital Enugu. Ekenze OS, Onwuekwe IO, Ezeala Adikaibe BA, Niger J Med 2010 19 4 419 422
22. Pattern of neurological admissions in the tropics: Experience at Kano, Northwestern Nigeria. Owolabi LF, Shehu MY, Shehu MN, Fadare J, Ann Indian Acad Neurol 2010 13 3 167 170
23. Longitudinal study of mortality predictors in Parkinson's disease in Nigerians. Okubadejo NU, Ojini FI, Danesi MA, Afr J Med Med Sci 2005 34 4 365 369
24. Frequency and predictors of autonomic dysfunction in Parkinson's disease: a study of African patients in Lagos, Nigeria. Okubadejo NU, Danesi MA, Niger Postgrad Med J 2004 11 1 45 49
25. Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria. Okubadejo NU, Ojo OO, Oshinaike OO, BMC neurology 2010 10 1
26. Assessing the prevalence of PINK1 genetic variants in South African patients diagnosed with early- and late-onset Parkinson's disease. Keyser RJ, Lesage S, Brice A, Carr J, Bardien S, Biochem Biophys Res Commun 2010 398 1 125 129
27. Factors influencing the development of early- or late-onset Parkinson's disease in a cohort of South African patients. van der Merwe C, Haylett W, Harvey J, Lombard D, Bardien S, Carr J, S Afr Med J 2012 102 11 Pt 1 848 851
28. Clinical profile of parkinsonian disorders in the tropics: Experience at Kano, northwestern Nigeria. Femi OL, Ibrahim A, Aliyu S, J Neurosci Rural Pract 2012 3 3 237 241
29. Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana. Cilia R, Sironi F, Akpalu A, Cham M, Sarfo FS, Brambilla T, Bonetti A, Amboni M, Goldwurm S, Pezzoli G, J Neurol 2012 259 3 569 570
30. Profile of clinically-diagnosed dementias in a neuropsychiatric practice in Abeokuta, South-Western Nigeria. Amoo G, Akinyemi RO, Onofa LU, Akinyemi JO, Baiyewu O, Ogunlesi AO, Ogunniyi A, Afr J Psychiatry 2011 14 5 377 382
31. Bilan de fonctionnement d'une clinique de la memoire senegalaise. Ndiaye D, Sylla A, Toure K, Thiam MH, Gueye M, AJNS 2011 30 1 1 9
32. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Hendrie HC, Osuntokun BO, Hall KS, Ogunniyi AO, Hui SL, Unverzagt FW, Gureje O, Rodenberg CA, Baiyewu O, Musick BS, Am J Psychiatry 1995 152 10 1485 1492
33. Cerebral amyloid beta protein deposits and other Alzheimer lesions in non-demented elderly east Africans. Ogeng'o JA, Cohen DL, Sayi JG, Matuja WB, Chande HM, Kitinya JN, Kimani JK, Friedland RP, Mori H, Kalaria RN, Brain pathology 1996 6 2 101 107 (Pubitemid 26160500)
34. Risk factors and Alzheimer's disease: a comparative study of two communities. Hall K, Gureje O, Gao S, Ogunniyi A, Hui SL, Baiyewu O, Unverzagt FW, Oluwole S, Hendrie HC, Aust N Z J Psychiatry 1998 32 5 698 706 (Pubitemid 28497672)
35. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O, Gao S, Evans RM, Ogunseyinde AO, Adeyinka AO, Musick B, Hui SL, JAMA 2001 285 6 739 747 (Pubitemid 32167232)
36. Risk of mortality for dementia in a developing country: the Yoruba in Nigeria. Perkins AJ, Hui SL, Ogunniyi A, Gureje O, Baiyewu O, Unverzagt FW, Gao S, Hall KS, Musick BS, Hendrie HC, Int J Geriatr Psychiatry 2002 17 6 566 573 (Pubitemid 34678709)
37. Apolipoprotein E and mortality in African-Americans and Yoruba. Lane KA, Gao S, Hui SL, Murrell JR, Hall KS, Hendrie HC, J Alzheimers Dis 2003 5 5 383 390 (Pubitemid 37474767)
38. Autopsy survey for Alzheimer's disease in Nigerian Africans: a preliminary report. Osuntokun BOOA, Junaid TA, Lekwauwa UG, Afr J Med Med Sci 1995 24 1 75 79
39. The coloured elderly in Cape Town - a psychosocial, psychiatric and medical community survey. Part II. Prevalence of psychiatric disorders. Ben-Arie OSL, Teggin AF, Elk R, S Afr Med J 1983 64 27 1056 1061 (Pubitemid 14131801)
40. Rarity of dementia (by DSM-III-R) in an urban community in Nigeria. Ogunniyi AO, Osuntokun BO, Lekwauwa UB, Falope ZF, East Afr Med J 1992 69 2 64 68
41. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu O, Adeyinka A, Oluwole SO, Komolafe O, Hall KS, Unverzagt FW, Hui SL, Yang M, Hendrie HC, Ann Neurol 1995 38 3 463 465
42. Profile of dementia in a Nigerian community-types, pattern of impairment, and severity rating. Ogunniyi A, Gureje O, Baiyewu O, Unverzagt F, Hall KS, Oluwole S, Osuntokun BO, Hendrie HC, J Natl Med Assoc 1997 89 6 392 396 (Pubitemid 127455011)
43. Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study. Ogunniyi A, Baiyewu O, Gureje O, Hall KS, Unverzagt F, Siu SH, Gao S, Farlow M, Oluwole OS, Komolafe O, Hendrie HC, Eur J Neurol 2000 7 5 485 490 (Pubitemid 32530107)
44. Cognitive impairment in community-dwelling older Nigerians: clinical correlates and stability of diagnosis. Baiyewu O, Unverzagt FW, Ogunniyi A, Hall KS, Gureje O, Gao S, Lane KA, Hendrie HC, Eur J Neurol 2002 9 6 573 580 (Pubitemid 36961282)
45. Caring for individuals with dementia: the Nigerian experience. Ogunniyi A, Hall KS, Baiyewu O, Gureje O, Unverzagt FW, Gao S, Hendrie HC, West Afr J Med 2005 24 3 259 262 (Pubitemid 41715314)
46. The profile and impact of probable dementia in a sub-Saharan African community: Results from the Ibadan Study of Aging. Gureje O, Ogunniyi A, Kola L, J Psychosom Res 2006 61 3 327 333 (Pubitemid 44286900)
47. Risk factors for dementia in central Nigeria. Ochayi B, Thacher TD, Aging Ment Health 2006 10 6 616 620 (Pubitemid 44581986)
48. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R, Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H, Neurology 2006 66 2 223 227 (Pubitemid 43970158)
49. Prevalence of dementia in elderly living in two cities of Central Africa: the EDAC survey. Guerchet M, M'Belesso P, Mouanga AM, Bandzouzi B, Tabo A, Houinato DS, Paraiso MN, Cowppli-Bony P, Nubukpo P, Aboyans V, Clément JP, Dartigues JF, Preux PM, Dement Geriatr Cogn Disord 2010 30 3 261 268
50. Cognitive impairment and dementia in elderly people living in rural Benin, west Africa. Guerchet M, Houinato D, Paraiso MN, von Ahsen N, Nubukpo P, Otto M, Clement JP, Preux PM, Dartigues JF, Dement Geriatr Cogn Disord 2009 27 1 34 41
51. Incidence of and risk factors for dementia in the Ibadan study of aging. Gureje O, Ogunniyi A, Kola L, Abiona T, J Am Geriatr Soc 2011 59 5 869 874
52. Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study. Ogunniyi A, Gao S, Unverzagt FW, Baiyewu O, Gureje O, Nguyen JT, Smith-Gamble V, Murrell JR, Hake AM, Hall KS, Hendrie HC, Int Psychogeriatr 2011 23 3 387 394
53. Hypertension and incident dementia in community-dwelling elderly Yoruba Nigerians. Ogunniyi A, Lane KA, Baiyewu O, Gao S, Gureje O, Unverzagt FW, Murrell JR, Smith-Gamble V, Hall KS, Hendrie HC, Acta Neurol Scand 2011 124 6 396 402
54. Behavioral symptoms in community-dwelling elderly Nigerians with dementia, mild cognitive impairment, and normal cognition. Baiyewu O, Unverzagt FW, Ogunniyi A, Smith-Gamble V, Gureje O, Lane KA, Gao S, Hall KS, Hendrie HC, Int J Geriatr Psychiatry 2012 27 9 931 939
55. Factors associated with dementia among elderly people living in two cities in Central Africa: the EDAC multicenter study. Guerchet M, Mouanga AM, M'Belesso P, Tabo A, Bandzouzi B, Paraiso MN, Houinato DS, Cowppli-Bony P, Nubukpo P, Aboyans V, Clément JP, Dartigues JF, Preux PM, J Alzheimers Dis 2012 29 1 15 24
56. Prevalence of Dementia among Elderly People Living in Cotonou, an Urban Area of Benin (West Africa). Paraiso MN, Guerchet M, Saizonou J, Cowppli-Bony P, Mouanga AM, Nubukpo P, Preux PM, Houinato DS, Neuroepidemiology 2011 36 4 245 251
57. The prevalence of dementia in rural Tanzania: a cross-sectional community-based study. Longdon AR, Paddick SM, Kisoli A, Dotchin C, Gray WK, Dewhurst F, Chaote P, Teodorczuk A, Dewhurst M, Jusabani AM, Walker R, Int J Geriatr Psychiatry 2013 28 7 728 737
58. Psychiatric disorders in the aged: epidemiology and preventive measures. Lambo TA, West Afr Med J 1966 15 3 121 124
59. Psychiatric disorders in elderly Nigerians. Makanjuola RO, Trop Geogr Med 1985 37 4 348 351 (Pubitemid 16227239)
60. Neuropsychiatric disorders in Nigerians: 1914 consecutive new patients seen in 1 year. Gureje O, Osuntokun BO, Makanjuola JD, Afr J Med Med Sci 1989 18 3 203 209 (Pubitemid 19222078)
61. Beta A4-amyloid in the brains of non-demented Nigerian Africans. Osuntokun BO, Ogunniyi A, Akang EE, Aghadiuno PU, Ilori A, Bamgboye EA, Beyreuther K, Masters C, Lancet 1994 343 8888 56 (Pubitemid 24017624)
62. Apolipoprotein E polymorphism in elderly east Africans. Sayi JG, Patel NB, Premkumar DR, Adem A, Winblad B, Matuja WB, Mtui EP, Gatere S, Friedland RP, Koss E, Kalaria RN, East Afr Med J 1997 74 10 668 670
63. Psychiatric disorders in Nigerian nursing home residents. Baiyewu O, Adeyemi JD, Ogunniyi A, Int J Geriatr Psychiatry 1997 12 12 1146 1150 (Pubitemid 28010563)
64. Satisfaction with dementia care-giving in Nigeria-a pilot investigation. Uwakwe R, Int J Geriatr Psychiatry 2006 21 3 296 297
65. A comparative study to screen dementia and APOE genotypes in an ageing East African population. Chen CH, Mizuno T, Elston R, Kariuki MM, Hall K, Unverzagt F, Hendrie H, Gatere S, Kioy P, Patel NB, Friedland RP, Kalaria RN, Neurobiol Aging 2010 31 5 732 740
66. Risk factors for dementia in a senegalese elderly population aged 65 years and over. Toure KCM, Ndiaye M, Zunzunegui MV, Bacher Y, Diop AG, Ndiaye MM, Dement Geriatr Cogn Dis 2012 2 160 168
67. Facteur de risque de démence dans une population de personne âgées sénégalaises. Toure K, Coume M, Ndiaye ND, Thiam MH, Zunzunegui MV, Bacher Y, Tal DA, Gueye L, Sene-Diouf F, Ndiaye M, Thiam A, Amadou GD, Ndiaye MM, Afr J Neurol Sci 2009 28 1 1 15
68. Les demences en Afrique sub-Saharienne: Aspects cliniques et etiologiques en milieu hospitalier a Ouagadougou (Bourkina Fasso). Napon CTI, Niakara A, Ouango JG, Kabre A, Kabore J, AJNS 2009 28 1 37 43
69. The spectrum of neurological disorders in a Zambian tertiary care hospital. Siddiqi OK, Atadzhanov M, Birbeck GL, Koralnik IJ, J Neurol Sci 2009 290 1-2 1 5
70. Psychiatric morbidity in elderly patients admitted to non-psychiatric wards in a general/teaching hospital in Nigeria. Uwakwe R, Int J Geriatr Psychiatry 2000 15 4 346 354 (Pubitemid 30315751)
71. APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians. Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, Smith-Gamble V, Lane KA, Gao S, Hall KS, Hendrie HC, Murrell JR, Ann Neurol 2006 59 1 182 185 (Pubitemid 43042886)
72. Risk factors for incident Alzheimer's disease in African Americans and Yoruba. Ogunniyi A, Hall KS, Gureje O, Baiyewu O, Gao S, Unverzagt FW, Smith-Gamble V, Evans RE, Dickens J, Musick BS, Hendrie C, Metab Brain Dis 2006 21 2-3 235 240
73. The epidemiology of dependence in older people in Nigeria: prevalence, determinants, informal care, and health service utilization. A 10/66 dementia research group cross-sectional survey. Uwakwe R, Ibeh CC, Modebe AI, Bo E, Ezeama N, Njelita I, Ferri CP, Prince MJ, J Am Geriatr Soc 2009 57 9 1620 1627
74. Prevalence of dementia and dementia subtypes among community-dwelling elderly people in northern Nigeria. Yusuf AJ, Baiyewu O, Sheikh TL, Shehu AU, Int Psychogeriatr 2011 23 3 379 386
75. Estimate of the prevalence of cognitive impairment in an elderly population of the health center of Senegalese national retirement institution. Coume M, Toure K, Thiam MH, Zunzunegui MV, Bacher Y, Diop TM, Ndiaye MM, Geriatr Psychol Neuropsychiatr Vieil 2012 10 1 39 46
76. Assessment of mild cognitive impairment with mini mental state examination among adults in southeast Nigeria. Onwuekwe I, Ann Med Health Sci Res 2012 2 2 99 102
77. Neurologic and psychiatric manifestations of AIDS in Central African Republic. Belec L, Testa J, Vohito MD, Gresenguet G, Martin MI, Tabo A, Di Costanzo B, Georges AJ, Bull Soc Pathol Exot Filiales 1989 82 3 297 307 (Pubitemid 19207212)
78. Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. Howlett WP, Nkya WM, Mmuni KA, Missalek WR, AIDS 1989 3 5 289 296 (Pubitemid 19167471)
79. Neuropsychological deficit in haemophiliacs with human immunodeficiency virus. Turnbull O, Saling MM, Kaplan-Solms K, Cohn R, Schoub B, J Neurol Neurosurg Psychiatry 1991 54 2 175 177
80. Neurological complications of HIV-1-seropositive internal medicine inpatients in Kinshasa, Zaire. Perriens JH, Mussa M, Luabeya MK, Kayembe K, Kapita B, Brown C, Piot P, Janssen R, J Acquir Immune Defic Syndr 1992 5 4 333 340
81. WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, Sughondhabirom B, Mussa M, Naber D, Ndetei D, Schulte G, Sartorius N, Arch Gen Psychiatry 1994 51 1 51 61 (Pubitemid 24028998)
82. Psychological morbidity and HIV in Kenya. Carson AJ, Sandler R, Owino FN, Matete FO, Johnstone EC, Acta Psychiatr Scand 1998 97 4 267 271 (Pubitemid 28179262)
83. Neuropsychiatric HIV-1 infection study: in Kenya and Zaire cross-sectional phase I and II. Sebit MB, Cent Afr J Med 1995 41 10 315 322
84. Antiretroviral therapy improves cognitive impairment in HIV + individuals in sub-Saharan Africa. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E, Neurology 2006 67 2 311 314 (Pubitemid 44305421)
85. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E, AIDS 2005 19 13 1367 1374 (Pubitemid 41800672)
86. The frequency and profile of neurology in black South African HIV infected (clade C) patients-a hospital-based prospective audit. Modi G, Hari K, Modi M, Mochan A, J Neurol Sci 2007 254 1-2 60 64 (Pubitemid 46343742)
87. Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans S, J Neurovirol 2007 13 1 67 72 (Pubitemid 46510146)
88. Memory performance in HIV/AIDS-a prospective case control study. Odiase FE, Ogunrin OA, Ogunniyi AA, Can J Neurol Sci 2007 34 2 154 159 (Pubitemid 47000116)
89. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, McArthur JC, Ronald A, Sacktor N, Neurology 2007 68 5 350 355 (Pubitemid 46184210)
90. Pattern of neuropsychological performance among HIV positive patients in Uganda. Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E, Parsons TD, Ronald A, Sacktor N, BMC Neurol 2007 7 8
91. Cognitive function in HIV-seropositive Nigerians without AIDS. Salawu FK, Bwala SA, Wakil MA, Bani B, Bukbuk DN, Kida I, J Neurol Sci 2008 267 1-2 142 146 (Pubitemid 351248921)
92. The utility of a rapid screening tool for depression and HIV dementia amongst patients with low CD4 counts- a preliminary report. Singh D, Sunpath H, John S, Eastham L, Gouden R, Afr J Psychiatry 2008 11 4 282 286
93. Psychiatric symptoms and disorders in HIV infected mine workers in South Africa. A retrospective descriptive study of acute first admissions. Sall L, Salamon E, Allgulander C, Owe-Larsson B, Afr J Psychiatry 2009 12 3 206 212
94. Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. Ganasen KA, Fincham D, Smit J, Seedat S, Stein D, J Neurol Sci 2008 269 1-2 62 64
95. The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon. Njamnshi AKDVP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WE, J Acquir Immune Defic Syndr 2008 49 4 393 397
96. Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda. Sacktor N, Nakasujja N, Skolasky RL, Robertson K, Musisi S, Ronald A, Katabira E, Clifford DB, Neurology 2009 72 2 165 170
97. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: The case of Yaoundé-Cameroon. Njamnshi AKBA, Ongolo-Zogo P, Tabah EN, Lekoubou AZ, Yepnjio FN, Fonsah JY, Kuate CT, Angwafor SA, Dema F, Njamnshi DM, Kouanfack C, Djientcheu Vde P, Muna WF, Kanmogne GD, J Neurol Sci 2009 285 1-2 149 153
98. HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K, Musisi S, Katabira E, Ronald A, Clifford DB, Laeyendecker O, Quinn TC, Clin Infec Dis 2009 49 5 780 786
99. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. Nakasujja N, Skolasky RL, Musisi S, Allebeck P, Robertson K, Ronald A, Katabira E, Clifford DB, Sacktor N, BMC Psychiatry 2010 10 44
100. Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda. Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V, BMC Psychiatry 2011 11 205
101. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa. Choi Y, Townend J, Vincent T, Zaidi I, Sarge-Njie R, Jaye A, Clifford DB, J Neurovirol 2011 17 2 166 175
102. Neuropsychiatric and socioeconomic status impact antiretroviral adherence and mortality in rural Zambia. Birbeck GL, Kvalsund MP, Byers PA, Bradbury R, Mang'ombe C, Organek N, Kaile T, Sinyama AM, Sinyangwe SS, Malama K, Malama C, Am J Trop Med Hyg 2011 85 4 782 789
103. Clinical correlates of HIV-associated neurocognitive disorders in South Africa. Joska JA, Fincham DS, Stein DJ, Paul RH, Seedat S, AIDS Behav 2010 14 2 371 378
104. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, Njamnshi DM, Nchindap E, Franklin DR Jr, Ellis RJ, McCutchan JA, Binam F, Mbanya D, Heaton RK, Njamnshi AK, BMC neurology 2010 10 60
105. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. Lawler K, Mosepele M, Ratcliffe S, Seloilwe E, Steele K, Nthobatsang R, Steenhoff A, J Int AIDS Soc 2010 13 15
106. High prevalence of suspected HIV-associated dementia in adult Malawian HIV patients. Patel VN, Mungwira RG, Tarumbiswa TF, Heikinheimo T, van Oosterhout JJ, Int J STD AIDS 2010 21 5 356 358
107. HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia. Holguin A, Banda M, Willen EJ, Malama C, Chiyenu KO, Mudenda VC, Wood C, AIDS and behavior 2011 15 8 1895 1901
108. Validity of the International HIV Dementia Scale in South Africa. Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, Stein DJ, AIDS Patient Care STDS 2011 25 2 95 101
109. Effects of highly active antiretroviral therapy on cognitive functions in severely immune-compromised HIV-seropositive patients. Obiabo YO, Ogunrin OA, Ogun AS, J Neurol Sci 2012 313 1-2 115 122
110. Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa. Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, Paul RH, Stein DJ, Flisher AJ, AIDS Behav 2011 15 6 1197 1203
111. A multinational study of neurological performance in antiretroviral therapy-naive HIV-1-infected persons in diverse resource-constrained settings. Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, Kumarasamy N, Walawander A, Nair A, Tripathy S, Kanyama C, Hosseinipour M, Montano S, La Rosa A, Amod F, Sanne I, Firnhaber C, Hakim J, Brouwers P, AIDS Clinical Trials Group, J Neurovirol 2011 17 5 438 447
112. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting. Robbins RN, Remien RH, Mellins CA, Joska JA, Stein DJ, AIDS patient care and STDs 2011 25 10 587 593
113. Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC, PLoS One 2012 7 3 32898
114. Neurocognitive deficits in HIV-infected women and victims of childhood trauma. Spies G, Fennema-Notestine C, Archibald SL, Cherner M, Seedat S, AIDS Care 2012 24 9 1126 1135
115. Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia. Hestad KA, Menon JA, Silalukey-Ngoma M, Franklin DR Jr, Imasiku ML, Kalima K, Heaton RK, Africa. J Nerv Ment Dis 2012 200 4 336 342
116. The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study. Berhe T, Melkamu Y, Amare A, AIDS Res Ther 2012 9 11
117. Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study. Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, Stein DJ, BMC infectious diseases 2012 12 39
118. Reliability of the Lay Adherence Counsellor Administered Substance Abuse and Mental Illness Symptoms Screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a Primary care HIV Clinic in Cape Town, South Africa. Breuer E, Stoloff K, Myer L, Seedat S, Stein DJ, Joska J, AIDS and behavior 2012 16 6 1464 1471
119. Relationship between apolipoprotein E4 genotype and white matter integrity in HIV-positive young adults in South Africa. Hoare J, Westgarth-Taylor J, Fouche JP, Combrinck M, Spottiswoode B, Stein DJ, Joska JA, Eur Arch Psychiatry Clin Neurosci 2013 263 3 189 195
120. Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy. Oshinaike OO, Akinbami AA, Ojo OO, Ojini IF, Okubadejo UN, Danesi AM, AIDS Res Treat 2012 2012 581531
121. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. Royal W 3rd, Cherner M, Carr J, Habib AG, Akomolafe A, Abimiku A, Charurat M, Farley J, Oluyemisi A, Mamadu I, Johnson J, Ellis R, McCutchan JA, Grant I, Blattner WA, J Neurovirol 2012 18 3 191 199
122. Community-based study of neurological disorders in rural central Ethiopia. Tekle-Haimanot R, Abebe M, Gebre-Mariam A, Forsgren L, Heijbel J, Holmgren G, Ekstedt J, Neuroepidemiology 1990 9 5 263 277
123. Paraplegia in Senegal. Jacquin-Cotton L, Dumas M, Girard PL, Bull Soc Med Afr Noire Lang Fr 1970 15 2 206 220
124. Etude de 30 observations de Syndrome de sclérose latérale Amyotrophique observés en Côte d'Ivoire. Piquemal M, Beugre K, Boa Y, Giordano C, Afr J Neurol Sci 1982 1 31 40 (Pubitemid 13196036)
125. Motor neuron disease in blacks. Epidemiological observations in Natal. Cosnett JE, Bill PL, Bhigjee AI, S Afr Med J 1989 76 4 155 157 (Pubitemid 19230693)
126. The prognosis of motor neuron disease in Nigerian africans. A prospective study of 92 patients. Osuntokun BO, Adeuja AO, Bademosi O, J Neurol 1974 97 2 385 394
127. Motor neurone disease in the tropics: findings from Sudan. Abdulla MN, Sokrab TE, el Tahir A, Siddig HE, Ali ME, East Afr Med J 1997 74 1 46 48
128. Epidemiological and clinical aspects of amyotrophic lateral sclerosis in neurological clinic of Dakar. Sene DF, Ndiaye M, Toure K, Ndao AK, Thiam A, Diop AG, Ndiaye IP, Dakar Med 2004 49 3 167 171
129. Unusual form of motor neuron disease in Kenya. Adam AM, East Afr Med J 1992 69 2 55 57
130. Motor neuron disease in Rhodesian Africans. Wall DW, Gelfand M, J Neurol 1972 95 3 517 520
131. What is happening to motor neuron diseases in Nigeria? Imam I, Ogunniyi A, Ann African Medicine 2004 3 1 1 3
132. Amyotrophic lateral sclerosis in Africans. Harries JR, East Afr Med J 1955 32 8 333 335
133. Maladie de Charcot et syndromes de sclérose latérale amyotrophique au sénégal: Etude clinique de 27 observations 1968; 13(4):785-804. Collomb H, Virieu R, Dumas M, Lemercier G, Bull Soc Med Noire Lgue Fr 1968 13 4 785 804
134. Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis. Mutesa L, Pierquin G, Segers K, Vanbellinghen JF, Gahimbare L, Bours V, J Trop Pediatr 2008 54 5 350 352
135. Pathologie hérédodégénérative du système nerveux central dans un service de neurologie à Nouakchott. Traore H, Diagana M, Prieux PM, Debrock C, Ba A, Algadi B,MD, Afr J Neurol Sci 1998 17 30 36
136. Huntington disease in South African blacks. A report of 8 cases. Joubert J, Botha MC, S Afr Med J 1988 73 8 489 494
137. Huntington's disease confirmed by genetic testing in five African families. Silber E, Kromberg J, Temlett JA, Krause A, Saffer D, Mov Disord 1998 13 4 726 730 (Pubitemid 28334110)
138. Huntington disease in Burkina Faso. Kabore J, Ouedraogo A, Rev Neurol (Paris) 2000 156 12 1157 1158 (Pubitemid 32047175)
139. A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features. Bardien S, Abrahams F, Soodyall H, van der Merwe L, Greenberg J, Brink T, Carr J, Mov Disord 2007 22 14 2083 2089
140. Huntington's disease: genetic heterogeneity in black African patients. Magazi DS, Krause A, Bonev V, Moagi M, Iqbal Z, Dludla M, van der Meyden CH, S Afr Med J 2008 98 3 200 203 (Pubitemid 351516346)
141. Huntington's chorea in the Cape coloured community of South Africa. Hayden MR, Beighton P, S Afr Med J 1977 52 22 886 888 (Pubitemid 8272176)
142. The prevalence of Huntington's chorea in South Africa. Hayden MR, MacGregor JM, Beighton PH, S Afr Med J 1980 58 5 193 196 (Pubitemid 10036596)
143. Huntington's chorea on the island of Mauritius. Hayden MR, Berkowicz AL, Beighton PH, Yiptong C, S Afr Med J 1981 60 26 1001 1002
144. The high frequency of juvenile Huntington's chorea in South Africa. Hayden MR, MacGregor JM, Saffer DS, Beighton PH, J Med Genet 1982 19 2 94 97 (Pubitemid 12158579)
145. Hereditary neurodegenerative disorders in Nigerian Africans. Aiyesimoju AB, Osuntokun BO, Bademosi O, Adeuja AO, Neurology 1984 34 3 361 362 (Pubitemid 14173216)
146. Huntington chorea in Senegal. Stephany F, Mbaye PS, Jacquin-Cotton L, Ndiaye IP, Dakar Med 1984 29 1 75 83
147. Huntington's chorea in a black Rhodesian family. Samuels BL, Gelfand M, S Afr Med J 1978 54 16 648 651 (Pubitemid 9045836)
148. Huntington's chorea in a black family: a report of 2 cases. Glass J,
149. Huntington's disease in Tanzania. Scrimgeour EM, J Med Genet 1981 18 3 200 203 (Pubitemid 11126501)
150. Genetic aspects of Huntington's chorea: results of a national survey. Hayden MR, Beighton P, Am J Med Genet 1982 11 2 135 141 (Pubitemid 12222460)
151. The Huntington's chorea register of Tanzania. Scrimgeour EM, East Afr Med J 1982 59 4 280 282 (Pubitemid 13200775)
152. Huntington disease in black Zimbabwean families living near the Mozambique border. Scrimgeour EM, Pfumojena JW, Am J Med Genet 1992 44 6 762 766 (Pubitemid 23006106)
153. Huntington's disease in a Sudanese family from Khartoum. Scrimgeour EM, Samman Y, Brock DJ, Human genetics 1995 96 5 624 625
154. Huntington disease in a large family in southern Togo. Grunitzky EK, Gnamey DR, Nonon SA, Balogou A, Ann Med Interne (Paris) 1995 146 8 581 583 (Pubitemid 26124470)
155. Global prevalence of dementia: a Delphi consensus study. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimer's Disease International, Lancet 2005 366 2112 2117 (Pubitemid 41797645)
156. Prevalence and incidence of Parkinson's disease in Europe. von Campenhausen BB S, Regina W, Kai B, Cristina S, Werner P, Wolfgang O, Uwe S, Karin Berger RD, Eur Neuropsychopharmacol 2005 15 473 490
157. Screening for mental disorders, dementia and Alzheimer's disease. Ashford JW, Aging health 2008 4 4 399 432
158. The validity and reliability of a screening questionnaire for Parkinson's disease in a community. Kim JH, Cheong HK, Lee CS, Yi SE, Park KW, J Prev Med Public Health 2010 43 1 9 17
159. Validity of a modified Parkinson's disease screening questionnaire in India: effects of literacy of participants and medical training of screeners and implications for screening efforts in developing countries. Sarangmath N, Rattihalli R, Ragothaman M, Gopalkrishna G, Doddaballapur S, Louis ED, Muthane UB, Mov Disord 2005 20 12 1550 1556
160. Risk factors for vascular disease and dementia. Breteler MM, Bots ML, Ott A, Hofman A, Haemostasis 1998 28 3-4 167 173 (Pubitemid 29309598)
161. Alzheimer's disease. Blennow K, de Leon MJ, Zetterberg H, Lancet 2006 368 9533 387 403 (Pubitemid 44108123)
162. Update in the epidemiology of Parkinson's disease. Elbaz A, Moisan F, Curr Opin Neurol 2008 21 4 454 460
163. Neurodegeneration and ageing in the HAART era. Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G, J Neuroimmune Pharmacol 2009 4 2 163 174
164. Population Division, DESA, United Nations, World Population Ageing 1950-2050. http://www.un.org/en/development/desa/population/publications/pdf/ ageing/WorldPopulationAgeingReport2013.pdf